Skip to main content

FOLD- Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
CEO1.02M$14.80M-
Other464.6K$6.73M-
Other409.3K$5.93M-
Other221.8K$3.21M-
CFO143.6K$2.08M-

Activity

Buys and sells only

Transactions

10 filings · page 18
DateInsiderRoleTypeSharesPriceValueChg%SEC
Jan 4, 2021Whitman Burke W50DirectorBuy1,500$23.17$34,755.00+3.9%
Jan 4, 2021Campbell Bradley L66Chief Operating OfficerSale+OE10,514$22.17$233,124.82-3.3%
Jan 4, 2021Crowley John F67Chairman &CEOSell7,500$22.17$166,305.00-1.0%
Dec 21, 2020Quimi Daphne58Chief Financial OfficerSale+OE5,000$24.09$120,473.50-2.0%
Dec 15, 2020Crowley John F67Chairman &CEOSale+OE22,000$23.91$526,101.40-2.6%
Dec 14, 2020Do HungChief Science OfficerSell111,125$23.88$2,653,276.06-21.3%
Dec 1, 2020Crowley John F67Chairman &CEOSell7,500$22.77$170,776.50-0.9%
Dec 1, 2020Campbell Bradley L66Chief Operating OfficerSale+OE24,783$22.77$564,192.43-6.8%
Dec 1, 2020Whitman Burke W50DirectorBuy1,500$23.50$35,250.00+4.1%
Nov 4, 2020Prout Samantha68Principal Accounting OfficerSale+OE5,931$20.00$118,620.00-25.7%